15 May 2024 | 02:08 PM UTC
Bosnia and Herzegovina: Elevated measles activity reported in multiple areas, especially Sarajevo Canton, in May /update 2
Elevated measles activity reported in multiple areas in Bosnia and Herzegovina, especially Sarajevo Canton, in May. Confirm vaccination.
Health officials have reported elevated measles activity in multiple areas in Bosnia and Herzegovina, with an additional 1,556 cases reported April 15-May 12, bringing the total case count to 3,339 cases since Jan. 1. This is compared to the 10 measles cases reported for 2023. Sarajevo Canton (2,514 cases) is the most affected, followed by Tuzla Canton (565 cases), Zenica-Doboj Canton (183 cases), Central Bosnia Canton (58 cases), and Una-Sana Canton (13 cases). Local health officials have implemented outbreak response measures, including strengthening surveillance, communication with the public and healthcare professionals, and catch-up vaccination activities. This report represents the most complete data available as of May 15.
Visit a doctor to ensure vaccination against measles or immunity through previous infection. Practice basic health precautions. Call your medical provider if symptoms develop within three weeks of being in affected areas.
Measles vaccination coverage in Bosnia and Herzegovina was estimated at 58 percent in 2022, which is well below the 92-95 percent required to prevent wider community transmission. Health officials reported two cases of measles each in Bosnia and Herzegovina in 2022, 2021, and 2020, and 1,332 cases in 2019.
Measles is a very contagious viral disease that spreads through respiratory droplets created when an infected individual coughs, sneezes or speaks. Infected individuals can also expose people around them by contaminating surfaces with secretions from the nose, mouth, and throat. Symptoms typically appear 7-14 days after exposure but can develop up to 21 days after exposure. Symptoms generally include fever, cough, runny nose, red eyes, and a red rash that begins on the face and spreads downward. Serious complications - including pneumonia - can occur, especially in children younger than five years old, adults older than 20 years old, and individuals with a weakened immune system.
